The Journal welcomes original research, reviews, and case studies covering genetic disorders, chromosomal abnormalities, single-gene diseases, multifactorial inheritance, gene therapy, genetic counseling, pharmacogenomics, epigenetics, rare diseases, metabolic disorders, cancer genetics, cardiovascular genetics, neurogenetic conditions, prenatal genetic testing, and genetic screening programs across pediatric and adult populations. We also welcome research on CRISPR-based therapeutics and personalized medicine approaches.

Yes, members can upgrade their tier at any time during their active subscription period. Contact our membership services team to discuss transitioning between individual, student, institutional, or corporate memberships based on your evolving research needs. Upgrade fees are prorated based on remaining subscription time, ensuring fair value for your investment in professional development.

Our rigorous peer review process typically completes within 4-6 weeks, with members receiving priority processing. Our editorial board of genetics and molecular biology experts ensures thorough evaluation while maintaining efficient turnaround times for publication decisions. Authors receive regular status updates and constructive feedback throughout the review process to improve manuscript quality.

Absolutely. We particularly encourage research on rare and orphan genetic diseases that may receive limited attention elsewhere. This includes case studies, novel gene discoveries, therapeutic developments, diagnostic advances, and translational research that bridges basic science with clinical applications for patients with rare inherited conditions. Such studies contribute significantly to improving patient outcomes worldwide.

Open access publication ensures your genetic research is freely available to clinicians, researchers, patients, genetic counselors, policymakers, and patient advocacy groups worldwide without subscription barriers. This significantly increases citation potential, facilitates knowledge translation into clinical practice, accelerates genetic medicine advances, and enables collaboration across institutions and borders.

Yes, student members receive full publication privileges including unlimited manuscript submissions during their membership period. Students can publish as first author or co-author, building their academic portfolio in genetic research while benefiting from reduced Article Processing Charges. This provides an excellent foundation for early-career researchers entering the field of hereditary disease research.

We accept a wide range of manuscript types including original research articles, comprehensive reviews, systematic reviews and meta-analyses, case reports, case series, clinical genetics studies, laboratory protocols, short communications, letters to the editor, and commentaries. Special issues may focus on specific genetic conditions, emerging technologies, or therapeutic approaches, providing additional publication opportunities for members.

Members receive access to premium language editing and manuscript formatting services to ensure publication-ready submissions. Our editorial team provides guidance on manuscript structure, reference formatting, and figure preparation. Additionally, members benefit from expedited customer service response times and personalized support for any submission-related inquiries.